Detalhe da pesquisa
1.
BRAF and MEK inhibitor combinations induce potent molecular and immunological effects in NRAS-mutant melanoma cells: Insights into mode of action and resistance mechanisms.
Int J Cancer
; 154(6): 1057-1072, 2024 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38078628
2.
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.
Cell Rep Med
; 4(10): 101200, 2023 10 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37734378
3.
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decision.
Leukemia
; 35(10): 2948-2963, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34021250
4.
Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia.
Front Oncol
; 9: 899, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31572684
5.
Correction to: EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Cell Death Differ
; 26(1): 198, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29991745
6.
Incubation of Immune Cell Grafts With MAX.16H5 IgG1 Anti-Human CD4 Antibody Prolonged Survival After Hematopoietic Stem Cell Transplantation in a Mouse Model for Fms Like Tyrosine Kinase 3 Positive Acute Myeloid Leukemia.
Front Immunol
; 9: 2408, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30405611
7.
MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.
Cell Death Dis
; 9(8): 814, 2018 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-30050105
8.
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Cell Death Differ
; 24(4): 705-716, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28186500
9.
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia.
Blood Cancer J
; 8(3): 36, 2018 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29563490